Rhonda Pacheco

Rhonda Pacheco is Group Vice President of Cardiometabolic Health at Eli Lilly and Company. She leads efforts to develop and deliver innovative therapies addressing obesity and related conditions. With extensive experience in healthcare leadership, Rhonda is passionate about advancing equitable access to care and improving outcomes for underserved communities. Her work focuses on breaking systemic barriers and driving meaningful change in cardiometabolic health.